These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25893591)

  • 1. Accelerated partial breast irradiation through brachytherapy for ductal carcinoma in situ: factors influencing utilization and risks of second breast tumors.
    Liu Y; Schloemann DT; Lian M; Colditz GA
    Breast Cancer Res Treat; 2015 May; 151(1):199-208. PubMed ID: 25893591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance.
    Hattangadi JA; Taback N; Neville BA; Harris JR; Punglia RS
    J Natl Cancer Inst; 2012 Jan; 104(1):29-41. PubMed ID: 22180643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
    Liu Y; Colditz GA; Gehlert S; Goodman M
    Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.
    Zauls AJ; Watkins JM; Wahlquist AE; Brackett NC; Aguero EG; Baker MK; Jenrette JM; Garrett-Mayer E; Harper JL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):21-9. PubMed ID: 20951508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.
    Madubata CC; Liu Y; Goodman MS; Yun S; Yu J; Lian M; Colditz GA
    Breast Cancer Res Treat; 2016 Dec; 160(3):563-572. PubMed ID: 27771840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
    Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial.
    Becherini C; Meattini I; Livi L; Garlatti P; Desideri I; Scotti V; Orzalesi L; Sanchez LJ; Bernini M; Casella D; Nesi S; Nori J; Bianchi S; Pallotta S; Marrazzo L
    Tumori; 2019 Jun; 105(3):205-209. PubMed ID: 30474504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
    Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
    JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.
    Punglia RS; Jiang W; Lipsitz SR; Hughes ME; Schnitt SJ; Hassett MJ; Nekhlyudov L; Achacoso N; Edge S; Javid SH; Niland JC; Theriault RL; Wong YN; Habel LA
    Breast Cancer Res Treat; 2018 Feb; 167(3):751-759. PubMed ID: 29079937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.
    Kamrava M; Kuske RR; Anderson B; Chen P; Hayes J; Quiet C; Wang PC; Veruttipong D; Snyder M; Jeffrey Demanes D
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S404-11. PubMed ID: 25916980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ.
    Abbott AM; Portschy PR; Lee C; Le CT; Han LK; Washington T; Kinney M; Bretzke M; Tuttle TM
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):494-8. PubMed ID: 24074922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite(®) Registry Trial.
    Beitsch PD; Wilkinson JB; Vicini FA; Haffty B; Fine R; Whitworth P; Kuerer H; Zannis V; Lyden M
    Ann Surg Oncol; 2012 Oct; 19(10):3165-70. PubMed ID: 22836556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes of catheter-based accelerated partial breast brachytherapy and whole breast irradiation, a single institution experience.
    Jethwa KR; Kahila MM; Mara KC; Harmsen WS; Routman DM; Pumper GM; Corbin KS; Sloan JA; Ruddy KJ; Hieken TJ; Park SS; Mutter RW
    Breast Cancer Res Treat; 2018 May; 169(1):189-196. PubMed ID: 29349713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.